All in all, these findings highlight the therapeutic potential of structured exercise interventions in modulating STAT3 activity, offering a promising, non-pharmacological strategy to ameliorate muscle wasting and improve clinical outcomes in cancer cachexia. The gene discussed is STAT3; the disease is Cachexia.